VF
PBLA

Virtu Financial’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Virtu Financial’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed -$19K – 2606
2022
Q3 		$19K Buy
+3
New +$62.9K ﹤0.01% 1414

Other funds holding PBLA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu Financial's PBLA Position: Q4 2022 in Review

Virtu Financial sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q4 2022, closing a stake of 3 shares — an estimated $19K sold.

Virtu Financial first reported a position in PBLA in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 10 funds tracked by Wall St. Rank hold PBLA as of Q4 2022.

  • Virtu Financial reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 3 Panbela Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $19K.
  • Virtu Financial first reported a position in Panbela Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Virtu Financial's Panbela Therapeutics, Inc. Common Stock position peaked at $19K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.